Severe drug-induced interstitial lung disease after photoimmunotherapy with cetuximab–sarotalocan sodium in a patient with oropharyngeal cancer: A case report

Background: Photoimmunotherapy (PIT) using cetuximab–sarotalocan sodium (CS) is a novel therapy for unresectable or locally recurrent head and neck squamous cell carcinoma (HNSCC). CS is a conjugate of cetuximab (monoclonal antibody targeting epidermal growth factor receptor [EGFR]) and IR700 (light...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Sho Takuma, Masato Karayama, Risa Suzuki, Koichi Miyashita, Yusuke Inoue, Hideki Yasui, Hironao Hozumi, Yuzo Suzuki, Kazuki Furuhashi, Noriyuki Enomoto, Tomoyuki Fujisawa, Naoki Inui, Takafumi Suda
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Elsevier 2025-01-01
Reeks:	Respiratory Medicine Case Reports
Onderwerpen:	Cetuximab Cetuximab-sarotalocan sodium Photoimmunotherapy Drug-induced interstitial lung disease Lung injury Interstitial pneumonia
Online toegang:	http://www.sciencedirect.com/science/article/pii/S2213007125000966
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!